You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

Poster Competition for Early Career Physicians

Second Annual North Carolina Chapter, ACP Research, Innovations, and Clinical Vignette Poster Competition for Early Career Physicians


Date: Saturday, February 25, 2017

Location: Sheraton Imperial Hotel in Durham

Viewing Time begins: 10:00AM

Judging Time: 10:30-11:30 AM


Abstract submission deadline: December 15, 2016

Early Career Physicians are considered to be members of ACP within 16 years of graduating from medical school, and have completed residency/fellowship.


Type of Submissions: Research, Innovations, Clinical Vignettes

I. Research

Submissions can report clinical research, basic science research, or a systematic review of a clinical problem. Research abstracts concerned with efficiency, cost, method of health care delivery methods and medical decision-making are also encouraged.

Abstracts submitted for the research category should adhere to the following headings:

  1. Background
  2. Methods
  3. Results
  4. Conclusions

II. Innovations

Authors wishing to describe an innovative program are encouraged to submit to this category. This may include quality improvement project, patient safety measures, high value care innovations etc. The projects may be primarily be descriptive, but may also include preliminary data. A more rigorous evaluation of an innovative program should be submitted as a research abstract rather than as an innovation. All innovations submissions must report on an activity that has already been piloted or fully implemented in the healthcare setting. Ideas for innovations that are being planned but have not yet been implemented will not be selected.

Any type of innovation may be submitted, including (but not limited to) critical pathway development and dissemination, medical education, faculty development, handheld computers, electronic medical records, billing and collections, patient safety interventions, communications, and teamwork with other care team members.

Abstracts submitted for the innovations category should adhere to these headings:

  1. Background
  2. Purpose
  3. Description
  4. Conclusions

III. Clinical Vignettes

A clinical vignette is a report of one or more cases that illustrates a new disease entity or a prominent or unusual clinical feature of an established disease, highlights an area of clinical controversy in hospital medicine, or illustrates a unique patient safety issue. It may include a summary of pertinent patient history, physical findings, laboratory data, or management description. Clinical vignettes will be judged on originality, organization, writing ability, and relevance to hospital medicine.

Abstracts submitted for the clinical vignette category should adhere to these headings:

  1. Case presentation
  2. Discussion
  3. Conclusions


Length: Abstracts must not exceed 450 words.

IRB or other research approval: If human or animal species were exposed to risks not required by their medical needs during the study included in the abstract, the author affirms that the study was approved by an appropriate committee. If no such committee was available and informed consent was needed, the author affirms that approval was obtained in accordance with the principles set forth in “The Institutional Guide to DHEW Policy on Protection of Human Subjects” and the “Guide for the Care and Use of Laboratory Animals” published by the NIH.

Conflict of Interest Policy: All authors submitting abstracts to the Research, Innovations, and Clinical Vignette Competition are required to disclose any relationships with pharmaceutical companies, biomedical device manufacturers, or other organizations that could represent potential conflicts in their presentation. The submitting author is responsible for providing disclosure information for all co-authors. This requirement applies to currently existing relationships or relationships within the past year that relate to the abstract entry. The principal intent of this disclosure is not to prevent authors with a potential conflict from submitting an abstract or presenting their work. Rather, disclosure information will assist the abstract committee members in the review process.

Permissions: The author submitting this abstract acknowledges that s/he and all coauthors have seen and agree with the following: the contents of the abstract; responsibility for clinical trial data (if applicable); that the abstract has not been published in a peer-reviewed journal prior to December 31 of the current year (prior presentation of the abstract at other meetings is allowed); disclosures of financial interest in or support from, or equity.

Co-Authorship: The majority of the effort and first authorship must be on the part of the early career physician who is first author. Co-authors must be credited for their contributions. All first authors will be required to attest that they are within 16 years of completing medical school and have completed their residency/fellowship.


The top poster in each category will be recognized with a commemorative plaque, and winners’ names will be forwarded to the national ACP for recognition at the Young Innovators Program at the IM 17 meeting in San Diego, CA. There will also be a small inaugural national competition at IM 17 which participants can enter separately. Winners will be featured in the NC, ACP Governor’s Newsletter.


Please direct questions to Duncan Vincent or Emily Mullen, Program Co-Chairs for the NC ECP Poster Competition.